Key terms

About HUM

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest HUM news

Yesterday 6:16am ET Molina Healthcare price target lowered to $410 from $440 at Wells Fargo Yesterday 6:15am ET Centene price target raised to $93 from $89 at Wells Fargo Yesterday 6:06am ET Wells Fargo Keeps Their Buy Rating on Humana (HUM) Apr 08 6:17am ET Humana (HUM) Receives a Buy from Wells Fargo Apr 08 5:48am ET Humana price target raised to $326 from $310 at Barclays Apr 04 6:31am ET Thursday Macro & Markets Update – 04.04.24 Apr 04 5:40am ET Analysts Offer Insights on Healthcare Companies: Illumina (ILMN) and Humana (HUM) Apr 02 10:58am ET Insurer stocks tumble as Medicare Advantage rates disappoint Apr 02 10:00am ET Humana falls -9.8% Apr 02 9:53am ET Estee Lauder upgraded, Petco downgraded: Wall Street’s top analyst calls Apr 02 9:47am ET Humana falls -10.2% Apr 02 9:25am ET Hold Rating on Humana Amid Subdued Medicare Advantage Rate Increase Apr 02 8:31am ET Humana downgraded to Neutral from Buy at BofA Apr 02 8:21am ET Humana downgraded to Neutral from Buy at BofA Apr 02 7:44am ET Humana price target lowered to $396 from $427 at TD Cowen Apr 02 7:30am ET Healthcare Stocks Drop as Medicare Advantage Rate Falls Short Apr 02 5:29am ET Humana price target lowered to $310 from $356 at Barclays Apr 02 3:50am ET Analysts Offer Insights on Healthcare Companies: Humana (HUM), Baxter International (BAX) and Biomea Fusion (BMEA) Apr 01 4:35pm ET CMS finalizes payment update for 2025 Medicare Advantage, sees payments up 3.7% Mar 31 3:54am ET The Week That Was, The Week Ahead: Macro & Markets, March 31, 2024 Mar 21 4:25pm ET Humana initiated with a Market Perform at Raymond James Mar 20 9:25am ET Humana and DUOS launch initiative ‘enhancing’ care for U.S. veteran seniors Mar 13 9:47am ET Tesla downgraded, Southwest upgraded: Wall Street’s top analyst calls Mar 13 8:22am ET Argus cuts Humana to Hold on larger Medicare exposure amid higer utilization Mar 13 7:26am ET Humana downgraded to Hold from Buy at Argus Mar 07 4:35pm ET Humana files automatic mixed securities shelf Mar 07 9:30am ET Trump Stocks vs. Biden Stocks: A Cheat Sheet Mar 06 6:35am ET Barclays starts health care facilities, managed care group with Neutral view Mar 06 6:10am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Humana (HUM), Alnylam Pharma (ALNY) and Spyre Therapeutics (SYRE) Mar 05 4:31pm ET Humana initiated with an Equal Weight at Barclays Mar 05 10:02am ET Humana, Strive Health announce expansion of care for people with kidney disease Mar 05 7:42am ET Humana Confirms Earnings Forecast in Upcoming Investor Meetings

No recent press releases are available for HUM

HUM Financials

1-year income & revenue

Key terms

HUM Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

HUM Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms